J&J reports positive data for Erda-iDRS in bladder cancer

​J&J has reported encouraging results from a Phase I study of the investigational intravesical drug-releasing system, Erda-iDRS, in patients with intermediate- and high-risk NMIBC harbouring select FGFR alterations.

The post J&J reports positive data for Erda-iDRS in bladder cancer appeared first on Hospital Management.

 

Back to the Featured Stories

Featured Stories

KORU Medical secures certification under EU MDR for infusion pump
Novartis wins FDA approval for Cosentyx to treat paediatric HS patients
PsiQuantum and National Cancer Center Japan partner on quantum computing
Pilatus Biosciences doses first patient in PLT012 antibody trial
Abbott reports positive FreeDM2 study results for CGM

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us